BLECEVEVE

EUIPO EUIPO 2014 Trademark registered

The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark BLECEVEVE was filed as Word mark on 11/11/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/10/2015. The current status of the mark is "Trademark registered".

Extend brand

Trademark Details Last update: May 13, 2024

Trademark form Word mark
File reference 013448386
Application date November 11, 2014
Publication date March 3, 2015
Entry date June 10, 2015
Expiration date November 11, 2024

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis and autoimmune diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders and cystic fibrosis; pharmaceutical preparations for the treatment, prevention and diagnosis of dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders and hormonal diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines and muscle diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders and reproductive system diseases and disorders; Pharmaceutical preparations, including, pharmaceutical preparations for the treatment, prevention and diagnosis of sleep disorders, and urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Trademark history

Date Document number Area Entry
April 15, 2024 Extension, Notification of expiry of trade mark
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Published

ID: 11013448386